Stéphane Bancel

Stéphane Bancel (born 1972/1973) is a French billionaire businessman. He is the chief executive officer (CEO) and a 9% owner of Moderna, an American biotechnology company.

Stéphane Bancel
Born1972/1973 (age 47–48)[1]
France
EducationCentraleSupélec
University of Minnesota
Harvard Business School
OccupationBusinessman
Known forCEO and 9% owner of Moderna
Net worthUS$4.5 billion (December 2020)[2]
TitleCEO, Moderna
Term2013–

Early life

Bancel was born in France and earned master's degrees in engineering from CentraleSupélec of Paris-Saclay University (former École Centrale Paris) and the University of Minnesota.[1] He went on to earn an MBA from Harvard Business School.[3]

Career

Bancel was a sales director at Eli Lilly and Company, eventually becoming head of operations for Belgium.[3] In 2007, he became CEO of French diagnostics company BioMérieux.[3]

In 2011, Bancel joined Moderna, becoming CEO. Stat news reported that Bancel led a highly secretive culture with little outside review of its science or research.[3]

Personal life

Bancel has two children.[4] In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion.[1]

References
  1. Tognini, Giacomo (3 April 2020). "Moderna CEO Stéphane Bancel Becomes A Billionaire As Stock Jumps On Coronavirus Vaccine News". Forbes. Archived from the original on 3 April 2020. Retrieved 4 April 2020.
  2. "Forbes profile: Stéphane Bancel". Forbes. Retrieved 2 December 2020.
  3. Garade, Damien (13 September 2016). "Ego, ambition, and turmoil: Inside one of biotech's most secretive startups". Stat. Archived from the original on 16 November 2020. Retrieved 18 May 2020.
  4. "Story Details - Alumni - Harvard Business School". www.alumni.hbs.edu. Retrieved 2 December 2020.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.